The dollar amount of insider sales is negligible for a company of HCA's size. Monitor next quarter's payer mix trends and leverage metrics given the recent debt issuance, but this cluster alone does not warrant a change in view.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $504.89entry
- T+1 · 7d ago −0.09%α +0.27% · $504.42
- T+5 · 19h ago +1.36%α +3.06% · $511.78
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Two HCA executives (EVP/COO Foster and EVP/Chief Clinical Officer Schlosser) conducted open-market sales totaling $5.73M on November 4, 2026, just after the company reported Q3 earnings (revenue +3.6% YoY, GAAP EPS +4.5% YoY but net income -3.9%) and one day after a $1.95B debt issuance. The sales represent ~0.005% of market cap, a trivial amount relative to the $106.7B company, and are not material enough to signal a change in fundamentals.
Key Financial Metrics
Key Facts
- EVP/COO Jon M. Foster sold 10,000 shares at $514.07 for $5.14M on 2026-11-04 (open-market, no 10b5-1 plan)
- EVP/Chief Clinical Officer Michael J. Schlosser sold 1,200 shares at $494.65 for $594K on 2026-11-04 (open-market, no 10b5-1 plan)
- Total open-market sales: $5.73M, representing ~0.005% of HCA's $106.7B market cap
- Foster also exercised derivatives and had tax withholding on the same date (non-cash events)
- Sales occurred 8 days after Q3 2026 earnings (revenue $19.849B, GAAP EPS $7.27) and 1 day after a $1.95B debt issuance
- Net income attributable to HCA declined 3.9% YoY in Q3 2026
Financial Impact
Open-market sales of $5.73M, trivial relative to $106.7B market cap
Risk Factors
- Insider sales are small relative to market cap and likely routine portfolio diversification
- Q3 net income decline of 3.9% and $400M unfavorable payer mix shift remain headwinds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HCA-1794003148538 |
Track record
19 reports on HCA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $506.04 Now $511.78 +1.13% settles Feb 9
- Nov 6, 202610d ago SC 13D/A Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Viewing Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $494.99 Now $511.78 +3.39% settles Feb 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 2, 202614d ago 8-K Neutral 3/10 Entry $462.86 Now $511.78 +10.57% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $473.19 Now $511.78 +8.16% settles Jan 28
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $463.22 Now $511.78 +10.48% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers